ArticleSurgical endoscopy2026
Feasibility of laser speckle contrast imaging (LSCI) in colorectal surgery: a prospective comparison with indocyanine green (ICG) fluorescence angiography.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdequate bowel perfusion is essential for anastomotic healing in colorectal surgery. Indocyanine green (ICG) fluorescence angiography (FA) is currently considered the gold standard for intraoperative perfusion assessment. Laser speckle contrast imaging (LSCI) is an emerging, dye-free technology that enables real-time evaluation of microvascular blood flow. The aim of this study is to assess the feasibility of LSCI in elective colorectal surgery and to compare its performance with ICG-FA for intraoperative evaluation of bowel perfusion.
methodsA prospective study was conducted including consecutive patients undergoing elective laparoscopic colorectal surgery between September 2025 and March 2026. Bowel perfusion was assessed intraoperatively using both LSCI and ICG-FA. The primary endpoint was feasibility of LSCI, while the secondary endpoint was concordance between these two technologies in determining the bowel section line.
resultsTwenty-two patients were included: 7 right hemicolectomies, 11 left hemicolectomies, and 4 anterior rectal resections. LSCI and ICG-FA were successfully performed in all cases (100%). Overall concordance between LSCI and ICG-FA was 86.2%. Concordance was 100% for ileum and 57.1% for transverse colon in right hemicolectomy, 100% in left hemicolectomy and 75% in anterior resection of the rectum. Two postoperative complications were observed, both following anterior resection of the rectum: one patient developed postoperative ileus (Clavien-Dindo I), and one patient developed abdominal pain, fever of unknown origin, and intra-abdominal fluid collection requiring revision surgery, which did not reveal an anastomotic leak (Clavien-Dindo III-b). Mean hospital stay was 6 ± 4 days.
conclusionsLSCI appears to be a feasible tool for intraoperative assessment of bowel perfusion, demonstrating high concordance with ICG-FA. Its dye-free and real-time capabilities make it a promising adjunct to ICG-FA. Larger prospective, multicentre, randomized studies are warranted to further define the clinical impact of LSCI in evaluating bowel vascularization and its potential role in improving surgical outcomes.
Indexed as
Identifiers
42260176What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.